Rheumatoid Arthritis Quiz: Biosimilars in RA

News
Article

Biosimilars to several recognized biologic rheumatoid arthritis treatments are now approved for use in the United States. Test your knowledge with this quiz.

As of October 1, 2023, how many biosimilars had been approved for use in the United States?


Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
1 KOL is featured in this Insights series.
Related Content
Study Links Air Pollution Exposure During Pregnancy to Reduced Lung Function in Childhood

Study Links Air Pollution Exposure During Pregnancy to Reduced Lung Function in Childhood

Tim Smith
July 24th 2024
Article
Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD

Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD

Abigail Brooks, MA
July 18th 2024
Podcast
Pankaj Arora, MD | Credit: UAB

Pooled Cohort Equation Bests Life's Essential 8, Simple 7 for Predicting Long-Term CVD Risk

Patrick Campbell
July 24th 2024
Article
John Buse, MD, PhD | Credit: UNC School of Medicine

Diabetes Dialogue: CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 15th 2024
Podcast
Hemophilia A Gene Therapy Displays Superiority in Phase 3 AFFINE Trial| Image Credit: UCSF Health

Hemophilia A Gene Therapy Displays Superiority in Phase 3 AFFINE Trial

Connor Iapoce
July 24th 2024
Article
Semaglutide May Reduce Rates of Diabetic Retinopathy Outcomes | Image Credit: Twitter

Semaglutide May Reduce Rates of Diabetic Retinopathy Outcomes

Connor Iapoce
July 24th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.